Streetbeat News

Analyst Ratings

FDX

FedEx Corporation's shares are trading higher following Argus Research's decision to maintain a Buy rating on the stock and increase the price target from $240 to $260.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 4:14 pm

MANU

Jefferies analyst John Janedis maintains a Buy rating on Manchester United (NYSE:MANU) and raises the price target from $25 to $26.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 4:10 pm

MANU

Manchester United's shares move higher as Jefferies issues a note highlighting encouraging Q3 results, but potential transaction remains the focus.

Portfolio Pulse from Happy Mohamed

June 27, 2023 | 4:10 pm

PRTK

Paratek Pharmaceuticals (NASDAQ:PRTK) has acknowledged receipt of a letter from NexPoint Asset Management, but disagrees with its characterizations. Paratek will provide additional details on its acquisition by Gurnet Point Capital and Novo Holdings A/S when it files proxy materials with the SEC.

Portfolio Pulse from Happy Mohamed

June 27, 2023 | 4:04 pm

WING

In the last quarter, Wingstop (NASDAQ:WING) received 1 bullish, 7 somewhat bullish, and 7 indifferent analyst ratings. The company's average 12-month price target is $214.33, up 14.26% from the previous average of $187.58.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 4:01 pm

CCK

Crown Holdings (NYSE:CCK) has received positive analyst ratings in the last quarter, with an average 12-month price target of $99.4, a 4.63% increase over the past month. Analysts are bullish on the stock, with 3 bullish, 1 somewhat bullish, and 1 indifferent rating.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 4:01 pm

LBPH

Longboard Pharmaceuticals (NASDAQ:LBPH) has received 5 bullish analyst ratings in the last quarter, with an average 12-month price target of $16.2, up 47.27% from the previous average of $11.00.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 4:01 pm

CARS

In the last 3 months, 4 analysts have provided 12-month price targets for Cars.com (NYSE:CARS), with an average target of $24.0, up 3.23% from the previous average of $23.25. The ratings include 1 bullish and 3 somewhat bullish.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 4:00 pm

ACET

In the last quarter, Adicet Bio (NASDAQ:ACET) received 2 bullish, 2 somewhat bullish, and 2 indifferent analyst ratings. The average price target is $25.17, compared to the current price of $2.18, implying an upside. The average price target has increased by 25.85% over the past month.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 4:00 pm

ARHS

In the last 3 months, 5 analysts have offered 12-month price targets for Arhaus (NASDAQ:ARHS), with an average price target of $12.4, a high of $15.00, and a low of $9.00. The average price target has increased by 0.57% over the past month.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 4:00 pm